Healthcare provider profile · identity verified

Lunia Estela Collado, MD

Internal Medicine · PROVIDENCE, RI · NPI 1346801404

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	986	276
Amlodipine Besylate	Amlodipine Besylate	400	119
Omeprazole	Omeprazole	347	100
Lisinopril	Lisinopril	295	88
Levothyroxine Sodium	Levothyroxine Sodium	280	72
Olmesartan Medoxomil	Olmesartan Medoxomil	274	75
Metoprolol Succinate	Metoprolol Succinate	258	78
Metformin Hcl	Metformin Hcl	254	73
Losartan Potassium	Losartan Potassium	253	80
Gabapentin	Gabapentin	213	80
Jardiance	Empagliflozin	201	48
Furosemide	Furosemide	191	52
Albuterol Sulfate Hfa	Albuterol Sulfate	190	65
Rosuvastatin Calcium	Rosuvastatin Calcium	185	63
Duloxetine Hcl	Duloxetine Hcl	176	41
Trazodone Hcl	Trazodone Hcl	161	45
Montelukast Sodium	Montelukast Sodium	154	39
Famotidine	Famotidine	153	59
Spironolactone	Spironolactone	153	35
Fluticasone Propionate	Fluticasone Propionate	140	66
Pantoprazole Sodium	Pantoprazole Sodium	132	42
Tamsulosin Hcl	Tamsulosin Hcl	128	35
Sertraline Hcl	Sertraline Hcl	118	25
Alendronate Sodium	Alendronate Sodium	116	33
Metformin Hcl Er	Metformin Hcl	113	32
Hydrochlorothiazide	Hydrochlorothiazide	112	35
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	104	41
Carvedilol	Carvedilol	98	25
Soliqua 100-33	Insulin Glargine/Lixisenatide	98	17
Mirtazapine	Mirtazapine	83	27
Estradiol	Estradiol	82	47
Clopidogrel	Clopidogrel Bisulfate	77	17
Escitalopram Oxalate	Escitalopram Oxalate	77	21
Farxiga	Dapagliflozin Propanediol	75	24
Chlorthalidone	Chlorthalidone	71	27
Pravastatin Sodium	Pravastatin Sodium	71	22
Citalopram Hbr	Citalopram Hydrobromide	70	17
Ozempic	Semaglutide	68	20
Nortriptyline Hcl	Nortriptyline Hcl	65	23
Eliquis	Apixaban	62	15
Meloxicam	Meloxicam	59	36
Trulicity	Dulaglutide	59	16
Simvastatin	Simvastatin	58	19
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	57	18
Pregabalin	Pregabalin	57	16
Tizanidine Hcl	Tizanidine Hcl	56	30
Bisoprolol Fumarate	Bisoprolol Fumarate	54	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	53	27
Glipizide	Glipizide	48	14
Prednisone	Prednisone	47	39
Ventolin Hfa	Albuterol Sulfate	47	24
Ezetimibe	Ezetimibe	46	16
Torsemide	Torsemide	46	suppressed
Allopurinol	Allopurinol	44	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	44	15
Venlafaxine Hcl Er	Venlafaxine Hcl	44	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	43	11
Spiriva Respimat	Tiotropium Bromide	43	13
Oxycodone Hcl	Oxycodone Hcl	41	suppressed
Clonazepam	Clonazepam	40	suppressed
Hydrocortisone	Hydrocortisone	40	20
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	40	13
Sumatriptan Succinate	Sumatriptan Succinate	36	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	35	14
Bupropion Hcl Sr	Bupropion Hcl	34	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	33	suppressed
Arnuity Ellipta	Fluticasone Furoate	32	12
Diclofenac Sodium	Diclofenac Sodium	31	14
Potassium Chloride	Potassium Chloride	31	suppressed
Buspirone Hcl	Buspirone Hcl	30	14
Ibuprofen	Ibuprofen	30	17
Meclizine Hcl	Meclizine Hcl	30	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	29	15
Ondansetron Hcl	Ondansetron Hcl	29	suppressed
Alprazolam	Alprazolam	28	suppressed
Baclofen	Baclofen	28	13
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	28	suppressed
Lorazepam	Lorazepam	28	suppressed
Irbesartan	Irbesartan	27	suppressed
Breo Ellipta	Fluticasone/Vilanterol	26	suppressed
Incruse Ellipta	Umeclidinium Bromide	26	suppressed
Humalog Kwikpen U-100	Insulin Lispro	25	suppressed
Entresto	Sacubitril/Valsartan	24	suppressed
Azithromycin	Azithromycin	23	17
Valsartan	Valsartan	23	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	20	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Donepezil Hcl	Donepezil Hcl	20	suppressed
Propranolol Hcl	Propranolol Hcl	20	suppressed
Tramadol Hcl	Tramadol Hcl	20	suppressed
Atenolol	Atenolol	19	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Nystatin	Nystatin	19	14
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	19	suppressed
Telmisartan	Telmisartan	19	suppressed
Varenicline Tartrate	Varenicline Tartrate	19	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	16
Naltrexone Hcl	Naltrexone Hcl	18	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	17
Warfarin Sodium	Warfarin Sodium	18	suppressed
Bupropion Hcl	Bupropion Hcl	17	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	17	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	17	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	16	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	16	suppressed
Azelastine Hcl	Azelastine Hcl	16	suppressed
Lovastatin	Lovastatin	16	suppressed
Rybelsus	Semaglutide	16	suppressed
Vascepa	Icosapent Ethyl	16	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	16	suppressed
Xarelto	Rivaroxaban	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Cephalexin	Cephalexin	15	12
Terazosin Hcl	Terazosin Hcl	15	suppressed
Aripiprazole	Aripiprazole	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Ipratropium Bromide	Ipratropium Bromide	14	suppressed
Mounjaro	Tirzepatide	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	12
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	14	suppressed
Verapamil Er Pm	Verapamil Hcl	14	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	13	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Creon	Lipase/Protease/Amylase	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Trospium Chloride	Trospium Chloride	13	suppressed
Ammonium Lactate	Ammonium Lactate	12	suppressed
Glimepiride	Glimepiride	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	11

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error